- Home
- BIOR
as 11-15-2024 4:00pm EST
Biora Therapeutics Inc is a biotechnology company engaged in developing oral biotherapeutics. Its drug-device combinations could enable new treatment approaches in the delivery of therapeutics in two main areas: Targeted delivery of therapeutics to the site of disease in the gastrointestinal ("GI") tract, which is designed to improve outcomes for patients with Inflammatory Bowel Disease (IBD); and Systemic delivery of biotherapeutics, which are designed to replace injection with needle-free, oral delivery technology.
| Founded: | 2010 | Country: | United States |
| Employees: | N/A | City: | SAN DIEGO |
| Market Cap: | 12.6M | IPO Year: | 2020 |
| Target Price: | $150.00 | AVG Volume (30 days): | 121.2K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -10.46 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.03 - $19.90 | Next Earning Date: | 11-14-2024 |
| Revenue: | $892,000 | Revenue Growth: | 4855.56% |
| Revenue Growth (this year): | 32550% | Revenue Growth (next year): | 95.48% |
Latest Biora Therapeutics Inc. News
BIOR Breaking Stock News: Dive into BIOR Ticker-Specific Updates for Smart Investing
GlobeNewswire
4 days ago
Biora Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results
GuruFocus.com
5 days ago
Biora Therapeutics Inc (BIOR) Q3 2024 Earnings Report Preview: What To Look For
GlobeNewswire
10 days ago
Biora Therapeutics to Report Third Quarter 2024 Financial Results and Provide Corporate Update
MT Newswires
20 days ago
Biora Therapeutics Plans $3 Million Registered Direct Offering; Shares Fall
GlobeNewswire
20 days ago
Biora Therapeutics Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
GlobeNewswire
21 days ago
Biora Therapeutics Shares Progress on Smaller BioJet™ Clinical Device with Largest Payload of any Ingestible Injectable at the 14th Annual PODD Meeting
GlobeNewswire
a month ago
Biora Therapeutics to Reveal 00-Size BioJet™ Device at the 14th Annual Partnership Opportunities in Drug Delivery Meeting
MT Newswires
a month ago
Biora Therapeutics Board Approves 1-for-10 Reverse Stock Split
Compare BIOR vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BIOR Biora Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.